Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data (Q33516585)

27 July 2017

title

Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data (English)

1 reference

27 July 2017

1 reference

Agnès Poirier

1

1 reference

27 July 2017

Anne-Christine Cascais

series ordinal

2

1 reference

27 July 2017

Christoph Funk

series ordinal

3

1 reference

27 July 2017

Thierry Lavé

series ordinal

4

1 reference

27 July 2017

publication date

20 November 2009

1 reference

Journal of Pharmacokinetics and Pharmacodynamics

27 July 2017

published in

1 reference

27 July 2017

volume

36

1 reference

27 July 2017

issue

6

1 reference

27 July 2017

page(s)

585-611

1 reference

Uptake of teicoplanin by isolated rat hepatocytes: comparison with in vivo hepatic distribution

27 July 2017

cites work

1 reference

12 December 2020

Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro model

1 reference

12 December 2020

A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes

1 reference

12 December 2020

Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats.

1 reference

12 December 2020

Interspecies scaling of biliary excreted drugs

1 reference

12 December 2020

Membrane transport as a determinant of the hepatic elimination of drugs and metabolites

1 reference

12 December 2020

Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans

1 reference

12 December 2020

Protein binding in plasma of valsartan, a new angiotensin II receptor antagonist

1 reference

12 December 2020

Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches.

1 reference

12 December 2020

In vitro-in vivo correlation of hepatobiliary drug clearance in humans.

1 reference

12 December 2020

Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes

1 reference

12 December 2020

In vivo use of the P450 inactivator 1-aminobenzotriazole in the rat: varied dosing route to elucidate gut and liver contributions to first-pass and systemic clearance

1 reference

12 December 2020

Interspecies pharmacokinetic comparisons and allometric scaling of napsagatran, a low molecular weight thrombin inhibitor

1 reference

12 December 2020

Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes

1 reference

12 December 2020

Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system

1 reference

12 December 2020

Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics

1 reference

12 December 2020

Hepatocyte suspensions and cultures as tools in experimental carcinogenesis

1 reference

12 December 2020

Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family

1 reference

12 December 2020

In vitro biliary clearance of angiotensin II receptor blockers and 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in sandwich-cultured rat hepatocytes: comparison with in vivo biliary clearance.

1 reference

12 December 2020

Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytes

1 reference

12 December 2020

Prediction of human pharmacokinetics-biliary and intestinal clearance and enterohepatic circulation

1 reference

12 December 2020

An evaluation of the utility of physiologically based models of pharmacokinetics in early drug discovery.

1 reference

12 December 2020

Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution.

1 reference

12 December 2020

Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance

1 reference

12 December 2020

Absolute difference of hepatobiliary transporter multidrug resistance-associated protein (MRP2/Mrp2) in liver tissues and isolated hepatocytes from rat, dog, monkey, and human.

1 reference

12 December 2020

Extensive biliary excretion of the sulfasalazine analogue, susalimod, but different concentrations in the bile duct in various animal species correlating to species-specific hepatobiliary toxicity

1 reference

12 December 2020

Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions

1 reference

12 December 2020

Scaling factors to relate drug metabolic clearance in hepatic microsomes, isolated hepatocytes, and the intact liver: studies with induced livers involving diazepam.

1 reference

12 December 2020

1 reference

12 December 2020

Challenges and opportunities with modelling and simulation in drug discovery and drug development

1 reference

12 December 2020

Structural and functional polarity of canalicular and basolateral plasma membrane vesicles isolated in high yield from rat liver

1 reference

12 December 2020

Influence of isolation procedure, extracellular matrix and dexamethasone on the regulation of membrane transporters gene expression in rat hepatocytes

1 reference

12 December 2020

Utility of Hepatocytes in Predicting Drug Metabolism: Comparison of Hepatic Intrinsic Clearance in Rats and Humans in Vivo and in Vitro

1 reference

12 December 2020

Hepatic canalicular membrane. Introduction: transport across the hepatocyte canalicular membrane

1 reference

12 December 2020

Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance

1 reference

12 December 2020

Effect of plasma protein binding on in vitro-in vivo correlation of biliary excretion of drugs evaluated by sandwich-cultured rat hepatocytes

1 reference

12 December 2020

Valsartan. A review of its pharmacology and therapeutic use in essential hypertension

1 reference

12 December 2020

Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes.

1 reference

12 December 2020

Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria

1 reference

12 December 2020

A novel strategy for physiologically based predictions of human pharmacokinetics

1 reference

12 December 2020

The role of hepatic transporters in drug elimination

1 reference

12 December 2020

Use of canalicular membrane vesicles (CMVs) from rats, dogs, monkeys and humans to assess drug transport across the canalicular membrane

1 reference

12 December 2020

Misuse of the well-stirred model of hepatic drug clearance.

1 reference

12 December 2020

Effect of culture conditions on the expression and function of Bsep, Mrp2, and Mdr1a/b in sandwich-cultured rat hepatocytes

1 reference

12 December 2020

Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases.

1 reference

12 December 2020

Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine

1 reference

12 December 2020

Pharmacokinetics, disposition and biotransformation of [14C]-radiolabelled valsartan in healthy male volunteers after a single oral dose

1 reference

12 December 2020

Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo

1 reference

12 December 2020

Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man

1 reference

12 December 2020

Recent progresses in the experimental methods and evaluation strategies of transporter functions for the prediction of the pharmacokinetics in humans

1 reference

12 December 2020

Hepatic bile entry into and transit pattern within the gallbladder lumen: a new quantitative cholescintigraphic technique for measurement of its concentration function.

1 reference

12 December 2020

Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.

1 reference

12 December 2020

Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril

1 reference

12 December 2020

Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs

1 reference

12 December 2020

Application of full physiological models for pharmaceutical drug candidate selection and extrapolation of pharmacokinetics to man

1 reference

12 December 2020

Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans

1 reference

12 December 2020

Simulation and prediction of in vivo drug metabolism in human populations from in vitro data

1 reference

12 December 2020

10.1007/S10928-009-9139-3

Identifiers

DOI

1 reference

Dimensions Publication ID

27 July 2017

1024218284

0 references

1 reference